Protein Biochips Market May Reach $430 Million By 2007

NEW YORK, Aug 6 (GenomeWeb News) - The protein biochip systems market was worth $170 million last year, and may eventually reach $430 million by 2007, the Bioperspectives pharmaceutical consulting company said last week.

Biochip technologies including DNA chip systems and protein chips are seen as the next logical step forward in the research and development of drugs, the report said.

Though protein biochips systems are growing quickly, they still lag behind DNA chips systems in the market, which were estimated to be worth $1 billion last year.

It is well known that genomic and proteomic chip technologies have been enormously successful in finding changes in expression between genes and proteins in normal and diseased states. The report, however, identified protein biochips as a key technology in determining if changes in proteins correlate with disease states and/or treatments.

Read an interview with the report's author, Steven Bodovitz, in the Aug. 13 issue of ProteoMonitor.